Advertisement
Boston Scientific
Subscribe to Boston Scientific

The Lead

CE Mark for Boston Scientific’s Full-Body MRI Safe Pacemaker

October 17, 2014 9:14 am | by PR Newswire | News | Comments

Boston Scientific Corporation has received CE Mark approval for the ACCOLADE pacemaker family. When implanted with the company's INGEVITY leads, ACCOLADE pacemakers are the first to enable patients to receive full-body MRI scans in both 1.5...

MDPC Publishes Robust Security Risk Assessment Framework for Medical Devices

September 26, 2014 10:56 am | by Medical Device Privacy Consortium | News | Comments

The Medical Device Privacy Consortium's Product Security Working Group has developed a robust...

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus Valve System

September 24, 2014 10:42 am | by PR Newswire | News | Comments

Boston Scientific Corporation has initiated the REPRISE III clinical trial, a pivotal study to...

CE Mark for Boston Scientific's Deep Brain Stimulation System for Treating Tremor

September 17, 2014 9:17 am | by PR Newswire | News | Comments

Boston Scientific Corporation has received CE Mark for the Vercise Deep Brain Stimulation (DBS)...

View Sample

FREE Email Newsletter

Boston Scientific Closes Acquisition of Interventional Business of Bayer AG

September 2, 2014 9:32 am | by Boston Scientific | News | Comments

Boston Scientific Corporation closed on its previously announced agreement to purchase the Interventional business of Bayer AG. The acquisition enhances the ability of Boston Scientific to offer physicians and healthcare systems a more complete...

Boston Scientific Launches POLARIS Imaging System

July 22, 2014 9:33 am | by PR Newswire | News | Comments

Boston Scientific Corporation has initiated full commercial launch of the new POLARIS Imaging System. This system will support the Boston Scientific family of intravascular ultrasound (IVUS) catheters, including coronary, peripheral and intra...

FDA Approval for Boston Scientific’s REBEL Platinum Chromium Coronary Stent System

July 22, 2014 9:06 am | by PRNewswire | News | Comments

Boston Scientific Corporation has received FDA approval for the REBEL Platinum Chromium Coronary Stent System, the company's latest generation bare-metal stent for the treatment of coronary artery disease (CAD). Bare-metal stents continue...

Advertisement

Boston Scientific Receives CE Mark for TAVI System

July 15, 2014 8:51 am | by PR Newswire | News | Comments

Boston Scientific Corporation has received CE Mark and begun the European commercial launch of its new 25 mm Lotus Transcatheter Aortic Valve Implantation (TAVI) System, complementing the currently available 23 mm and 27 mm valve sizes... 

Boston Scientific Receives CE Mark for Ranger Drug-Coated Balloon

July 14, 2014 9:31 am | by PR Newswire | News | Comments

Demonstrating its continued leadership in the development of innovative solutions for peripheral vascular disease, Boston Scientific Corporation has received CE Mark for the Ranger Paclitaxel-Coated PTA Balloon Catheter. The technology is...

Strong Performance Data Reported for SYNERGY Stent System Trial

May 21, 2014 2:07 pm | by Boston Scientific | News | Comments

Boston Scientific Corporation reported positive three-year follow-up data for the EVOLVE clinical trial, comparing the safety and performance of the SYNERGY Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium (PtCr) Coronary Stent...

Lotus Valve System Demonstrates Strong Performance and Safety Profile at Six Months

May 21, 2014 1:56 pm | by Boston Scientific | News | Comments

Further validating its advanced transcatheter aortic valve implantation (TAVI) technology, the Boston Scientific Corporation Lotus Valve System continued to demonstrate impressive performance at six months, according to new data presented...

Boston Scientific to Acquire Bayer’s Interventional Division for $415 Million

May 15, 2014 9:58 am | by Boston Scientific | News | Comments

In a move to expand significantly its portfolio of leading solutions for peripheral interventions, Boston Scientific Corporation has entered into a definitive agreement to acquire the Interventional Division of Bayer AG for $415 million in...

Advertisement

Common Test Used on Heart Patients Who Need Defibrillator Implants Unnecessary

May 9, 2014 12:05 pm | by McMaster University | News | Comments

New research from McMaster University suggests that a commonly performed test during certain types of heart surgery is not helpful and possibly harmful. The testing procedure, known as defibrillator testing (DT), is commonly used on people...

Boston Scientific Gets Heart Device Subpoena

May 9, 2014 11:05 am | by The Associated Press | News | Comments

Medical device maker Boston Scientific said Thursday the U.S. government wants documents related to its Cognis and Teligen heart devices. The company said in a regulatory filing that the U.S. Department of Health and Human Services wants...

Boston Scientific to Acquire IoGyn Inc.

May 7, 2014 11:42 am | by Boston Scientific | News | Comments

Boston Scientific Corporation has signed a definitive agreement to acquire IoGyn, Inc., a pre-commercial stage company. The transaction is expected to close within days. IoGyn has developed and received U.S. Food and Drug Administration...

Boston Scientific Joins Optum Labs as Founding Medical Device Partner

May 6, 2014 7:37 am | by PR Newswire | News | Comments

Boston Scientific Corporation has joined Optum Labs as the Founding Medical Device Partner to help pioneer new research into effective treatments for heart failure and related cardiac conditions. Optum Labs is an open collaborative healthcare...

Boston Scientific Launches Everolimus-Eluting Coronary Stent In Japan

May 1, 2014 12:45 am | by PR Newswire | News | Comments

Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation has launched the Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System in Japan.  This advanced DES system recently...  

Advertisement

Boston Scientific Begins Clinical Trial for Pacing Leads

April 23, 2014 9:24 am | by Boston Scientific | News | Comments

Boston Scientific Corporation has conducted the first implant in the clinical trial of the next generation ACUITY X4 left-ventricular (LV) pacing leads and RELIANCE 4-FRONT defibrillation (ICD) leads. The clinical trial is designed to establish...

FDA Approval for New Defibrillators and Heart Failure Devices

April 16, 2014 10:17 am | by Boston Scientific | News | Comments

Boston Scientific Corporation has received FDA approval for its latest generation of defibrillators and heart failure devices designed to advance patient care. The newly approved devices include the DYNAGEN MINI and INOGEN MINI ICDs, as well as...

Preliminary Injunction Against Guidezilla Catheter Vacated by Federal Circuit

April 16, 2014 10:09 am | by Vascular Solutions | News | Comments

Vascular Solutions, Inc. announced that a three judge panel of the U.S. Court of Appeals for the Federal Circuit today vacated the preliminary injunction that was previously issued by the District Court for the District of Minnesota effective...

First Patient Enrolled in Clinical Registry Assessing Boston Scientific Vercise Deep Brain Stimulation System in Patients with Parkinson's Disease

April 11, 2014 10:07 am | by PR Newswire | News | Comments

Boston Scientific Corporation has enrolled the first patient in a new registry to evaluate clinical outcomes and the economic value of the Vercise™ Deep Brain Stimulation (DBS) System in patients with Parkinson's disease. DBS is a surgical...

Cardiac Device Keeps Heart Going

April 8, 2014 3:15 pm | by Jennifer R. Lloyd, San Antonio Express-News | News | Comments

With a weak heart muscle and heart valve problems, Ruben Rivera said he was apprehensive about having a new type of battery-powered defibrillator implanted under his skin that could shock his heart if it sensed an irregular rhythm. But the...

Boston Scientific's Endoscopic Ultrasound Needle Is for Use During Fine Needle Aspiration Procedures

April 7, 2014 6:31 pm | by PR Newswire | News | Comments

Boston Scientific Corporation has received clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval in Europe for the Expect™ Slimline (SL) Needle, which is now globally available for Endoscopic Ultrasound-Fine Needle...

New Long-term Data Demonstrate Patients with Mild Heart Failure Sustained Lower Mortality Rates after Receiving Boston Scientific CRT Defibrillators

March 31, 2014 12:27 pm | by Boston Scientific | News | Comments

In the longest follow-up to date of cardiac resynchronization therapy (CRT) for mild heart failure patients, Boston Scientific Corporation's (NYSE: BSX) exclusively sponsored and landmark Multicenter Automatic Defibrillator Implantation Trial...

Deep Brain Stimulation Devices Market for Parkinson's disease Expected to Reach USD 9.4 Billion Globally in 2019

March 18, 2014 7:28 am | by PR Newswire | News | Comments

According to a new market report published by Transparency Market Research "Deep Brain Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia-Pacific and Latin America)- Global Industry Analysis, Size, Share, Growth...

Boston Scientific Announces CE Mark Approval and First Implants of Ingevity MRI Pacing Leads

March 14, 2014 10:35 am | by PR Newswire | News | Comments

Boston Scientific Corporation announces CE Mark approval and European market launch of the INGEVITY family of magnetic resonance imaging (MRI) compatible pacing leads. Pacing leads are insulated wires that connect an implantable pacemaker...

Boston Scientific Receives CE Mark Approval for REBEL Platinum Chromium Coronary Stent System

March 12, 2014 7:33 pm | by PR Newswire | News | Comments

Continuing to advance leading stent technology, Boston Scientific Corporation has received CE Mark approval for the REBEL Platinum Chromium Coronary Stent System, the company's latest generation bare metal stent for the treatment of coronary...

Boston Scientific Esophageal Stent Gains CE Mark

February 19, 2014 10:15 am | by PRNewswire | News | Comments

Boston Scientific Corporation has received CE Mark in Europe for its WallFlex Esophageal Fully Covered Stent to treat refractory benign esophageal strictures. Benign esophageal strictures are a narrowing of the esophagus caused by scar tissue...

Boston Scientific saw 5% revenue growth at end of 2013

February 5, 2014 2:00 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Delivering his first annual report after a full year as head of the state’s largest medical device company, CEO Mike Mahoney reported that the last three months of 2013 saw revenues rise 5 percent over the previous year, providing what he...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading